IL10 and infection: The increased effectiveness of anti-ICOS administration in inhibiting IL-10–GFP expression from day 3 of infection compared with its effectiveness with administration from day −1 is potentially due to the development of compensatory immune mechanisms when administration was commenced before immune priming, which subsequently reduced the relative importance of ICOS in maintaining IL-10 expression in CD4+ YFP+ T cells.